Factors influencing kidney cancer outcomes with immunotherapy
This video interview discusses the effect of certain factors such [...]
Nivolumab plus ipilimumab and live bacteria supplements in advanced kidney cancer
Researchers are interested in the bacteria in our gut (the [...]
ASCO 2021: Gut microbiome boosts nivolumab/ipilimumab activity
Recent evidence suggests that the bacteria in the gut (the [...]
Effect of antibiotics on outcomes with systemic treatments for metastatic kidney cancer
The microbes in the gut (the gut microbiome) are a [...]
